Foreign investors from Ukraine acquired the Trieste business unit of SM Farmaceutici S.r.l., which produces infusion solutions. Arkios Italy supported SM Farmaceutici throughout the transaction process with Diaco Biofarmaceutici S.r.l., including negotiations, due diligence, and finalizing investment contracts. The Ukrainian investors intend to invest in and expand production at the Trieste plant. This was Arkios Italy's 16th M&A transaction since 2009, demonstrating their expertise in mergers and acquisitions for Italian small and medium-sized enterprises.